{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:02:14Z","timestamp":1791180134080,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":746,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"British Heart Foundation, Medical Research Council"},{"name":"NIHR Imperial Healthcare Comprehensive Biomedical Research Centre"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.jacc.2011.02.057","type":"journal-article","created":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T00:35:53Z","timestamp":1309998953000},"page":"300-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":237,"title":["Iron Deficiency and Raised Hepcidin in Idiopathic Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"58","author":[{"given":"Christopher J.","family":"Rhodes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke S.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Busbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Ashby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eumorfia","family":"Kondili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Simon R.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wharton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2011.02.057_bib1","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/CIRCULATIONAHA.108.847707","article-title":"Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.02.057_bib2","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1152\/japplphysiol.00965.2001","article-title":"Desferrioxamine elevates pulmonary vascular resistance in humans: potential for involvement of HIF-1","volume":"92","author":"Balanos","year":"2002","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jacc.2011.02.057_bib3","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1113\/jphysiol.2008.160960","article-title":"The increase in pulmonary arterial pressure caused by hypoxia depends on iron status","volume":"586","author":"Smith","year":"2008","journal-title":"J Physiol"},{"key":"10.1016\/j.jacc.2011.02.057_bib4","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jama.2009.1404","article-title":"Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials","volume":"302","author":"Smith","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.02.057_bib5","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.amjcard.2009.05.016","article-title":"Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension","volume":"104","author":"Hampole","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2011.02.057_bib6","article-title":"Association of anemia and long-term survival in patients with pulmonary hypertension","author":"Krasuski","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2011.02.057_bib7","article-title":"Iron deficiency is common in idiopathic pulmonary arterial hypertension","author":"Ruiter","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2011.02.057_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of Mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2011.02.057_bib9","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1161\/01.CIR.0000012754.72951.3D","article-title":"Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor","volume":"105","author":"Atkinson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.02.057_bib10","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jacc.2009.04.015","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"54","author":"Machado","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.02.057_bib11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.335","article-title":"BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism","volume":"41","author":"Andriopoulos","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2011.02.057_bib12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1182\/blood-2008-03-143354","article-title":"Iron regulates phosphorylation of Smad1\/5\/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver","volume":"112","author":"Kautz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2011.02.057_bib13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.320","article-title":"Lack of the bone morphogenetic protein BMP6 induces massive iron overload","volume":"41","author":"Meynard","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2011.02.057_bib14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1053\/j.gastro.2009.09.048","article-title":"Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo","volume":"138","author":"Arndt","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacc.2011.02.057_bib15","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2011.02.057_bib16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/09674845.2009.11730263","article-title":"Development of a novel immunoassay for the iron regulatory peptide hepcidin","volume":"66","author":"Busbridge","year":"2009","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.jacc.2011.02.057_bib17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2141.1990.tb07806.x","article-title":"Serum transferrin receptor as an index of iron absorption","volume":"75","author":"Cook","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacc.2011.02.057_bib18","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.2009.21","article-title":"Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease","volume":"75","author":"Ashby","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2011.02.057_bib19","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2011.02.057_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1182\/blood.V75.1.102.102","article-title":"Intact transferrin receptors in human plasma and their relation to erythropoiesis","volume":"75","author":"Huebers","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2011.02.057_bib21","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3945\/ajcn.2009.28129","article-title":"Plasma hepcidin is a modest predictor of dietary iron bioavailability in humans, whereas oral iron loading, measured by stable-isotope appearance curves, increases plasma hepcidin","volume":"90","author":"Zimmermann","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacc.2011.02.057_bib22","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2011.02.057_bib23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2011.02.057_bib24","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1182\/blood-2007-09-111567","article-title":"Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin","volume":"111","author":"Xia","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2011.02.057_bib25","doi-asserted-by":"crossref","first-page":"24443","DOI":"10.1074\/jbc.M502825200","article-title":"Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells","volume":"280","author":"Yu","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacc.2011.02.057_bib26","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood-2006-06-028787","article-title":"Suppression of hepcidin during anemia requires erythropoietic activity","volume":"108","author":"Pak","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2011.02.057_bib27","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1629","article-title":"High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin","volume":"13","author":"Tanno","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2011.02.057_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3324\/haematol.2009.013136","article-title":"Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin","volume":"95","author":"Ashby","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jacc.2011.02.057_bib29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev.pathol.4.110807.092205","article-title":"Regulation of hepcidin and iron-overload disease","volume":"4","author":"Lee","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jacc.2011.02.057_bib30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1164\/rccm.200802-235OC","article-title":"Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension","volume":"178","author":"Nickel","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2011.02.057_bib31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jacc.2011.02.057_bib32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jacc.2011.02.057_bib33","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI15496","article-title":"Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia","volume":"111","author":"Brusselmans","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2011.02.057_bib34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1172\/JCI5912","article-title":"Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha","volume":"103","author":"Yu","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2011.02.057_bib35","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2353\/ajpath.2010.090832","article-title":"Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells","volume":"176","author":"Fijalkowska","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacc.2011.02.057_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.02.057_bib37","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli","year":"2007","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109711015555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109711015555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:46:25Z","timestamp":1760013985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109711015555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0735109711015555"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2011.02.057","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron Deficiency and Raised Hepcidin in Idiopathic Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2011.02.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}